US5498538A
(en)
*
|
1990-02-15 |
1996-03-12 |
The University Of North Carolina At Chapel Hill |
Totally synthetic affinity reagents
|
US5747334A
(en)
*
|
1990-02-15 |
1998-05-05 |
The University Of North Carolina At Chapel Hill |
Random peptide library
|
US5962219A
(en)
*
|
1990-06-11 |
1999-10-05 |
Nexstar Pharmaceuticals, Inc. |
Systematic evolution of ligands by exponential enrichment: chemi-selex
|
US5843701A
(en)
*
|
1990-08-02 |
1998-12-01 |
Nexstar Pharmaceticals, Inc. |
Systematic polypeptide evolution by reverse translation
|
US5795747A
(en)
*
|
1991-04-16 |
1998-08-18 |
Evotec Biosystems Gmbh |
Process for manufacturing new biopolymers
|
DE4112440C1
(ja)
*
|
1991-04-16 |
1992-10-22 |
Diagen Institut Fuer Molekularbiologische Diagnostik Gmbh, 4000 Duesseldorf, De |
|
AU2313392A
(en)
*
|
1991-08-01 |
1993-03-02 |
University Research Corporation |
Systematic polypeptide evolution by reverse translation
|
US5783384A
(en)
*
|
1992-01-13 |
1998-07-21 |
President And Fellows Of Harvard College |
Selection of binding-molecules
|
US5728802A
(en)
*
|
1992-05-06 |
1998-03-17 |
Affymax Technologies N.V. |
Peptides and compounds that bind selectins including endothelium leukocyte adhesion molecule 1 (ELAM-1)
|
US5648458A
(en)
*
|
1992-05-06 |
1997-07-15 |
Affymax Technologies N.V. |
Peptides and compounds that bind to ELAM-1
|
US5643873A
(en)
*
|
1992-05-06 |
1997-07-01 |
Affymax Technologies N.V. |
Peptides and compounds that bind selectins including endothelial leukocyte adhesion molecule 1
|
WO1994005812A1
(en)
*
|
1992-09-02 |
1994-03-17 |
The Scripps Research Institute |
Coupled isothermal polynucleotide amplification and translation system
|
US5922545A
(en)
*
|
1993-10-29 |
1999-07-13 |
Affymax Technologies N.V. |
In vitro peptide and antibody display libraries
|
AU8124694A
(en)
*
|
1993-10-29 |
1995-05-22 |
Affymax Technologies N.V. |
In vitro peptide and antibody display libraries
|
US5525735A
(en)
*
|
1994-06-22 |
1996-06-11 |
Affymax Technologies Nv |
Methods for synthesizing diverse collections of pyrrolidine compounds
|
US5525734A
(en)
*
|
1994-06-22 |
1996-06-11 |
Affymax Technologies N.V. |
Methods for synthesizing diverse collections of pyrrolidine compounds
|
US5885577A
(en)
*
|
1994-09-21 |
1999-03-23 |
Cytogen Corporation |
Antigen binding peptides (abtides) from peptide libraries
|
DE69526665T2
(de)
*
|
1994-09-21 |
2002-11-21 |
Cytogen Corp., Princeton |
Antigen bindende peptide (abtides) aus peptidbibliotheken
|
AU4522196A
(en)
*
|
1994-12-30 |
1996-07-24 |
Chiron Corporation |
Method for the controlled synthesis of polynucleotide mixtures which encode desired mixtures of peptides
|
US6341256B1
(en)
|
1995-03-31 |
2002-01-22 |
Curagen Corporation |
Consensus configurational bias Monte Carlo method and system for pharmacophore structure determination
|
US20010053523A1
(en)
*
|
1995-06-02 |
2001-12-20 |
M&E Biotech A/S. |
Method for identification of biologically active peptides and nucleic acids
|
US6537776B1
(en)
|
1999-06-14 |
2003-03-25 |
Diversa Corporation |
Synthetic ligation reassembly in directed evolution
|
US7888466B2
(en)
|
1996-01-11 |
2011-02-15 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor HSATU68
|
EP0912728A1
(en)
*
|
1996-05-31 |
1999-05-06 |
MediGene Aktiengesellschaft |
Novel synthetic protein structural templates for the generation, screening and evolution of functional molecular surfaces
|
US6875620B1
(en)
*
|
1996-10-31 |
2005-04-05 |
Agilent Technologies, Inc. |
Tiling process for constructing a chemical array
|
WO1998031700A1
(en)
|
1997-01-21 |
1998-07-23 |
The General Hospital Corporation |
Selection of proteins using rna-protein fusions
|
US6261804B1
(en)
*
|
1997-01-21 |
2001-07-17 |
The General Hospital Corporation |
Selection of proteins using RNA-protein fusions
|
US8207093B2
(en)
|
1997-01-21 |
2012-06-26 |
The General Hospital Corporation |
Selection of proteins using RNA-protein fusions
|
GB9703369D0
(en)
*
|
1997-02-18 |
1997-04-09 |
Lindqvist Bjorn H |
Process
|
GB2338237B
(en)
*
|
1997-02-18 |
2001-02-28 |
Actinova Ltd |
In vitro peptide or protein expression library
|
DE69834032T2
(de)
|
1997-04-23 |
2006-12-07 |
Universität Zürich |
Verfahren zur erkennung von nucleinsäuremolekülen codierend für (poly)peptide, welche mit zielmolekülen interagieren
|
DE69838521T2
(de)
|
1997-07-07 |
2008-05-21 |
Medical Research Council |
Methode zur Erhöhung der Konzentration von Nucleinsäuremolekülen
|
WO1999005256A2
(en)
*
|
1997-07-24 |
1999-02-04 |
President And Fellows Of Harvard College |
Method for cloning secreted proteins
|
US6927025B1
(en)
|
1997-09-03 |
2005-08-09 |
Biovation Limited |
Methods for protein screening
|
ATE311443T1
(de)
*
|
1997-09-03 |
2005-12-15 |
Biovation Ltd |
Methoden zur durchforstung (screenen) von proteinen
|
GB9722131D0
(en)
|
1997-10-20 |
1997-12-17 |
Medical Res Council |
Method
|
WO1999050461A1
(en)
|
1998-03-30 |
1999-10-07 |
Northwest Biotherapeutics, Inc. |
Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis
|
CA2323638A1
(en)
|
1998-04-03 |
1999-10-14 |
Phylos, Inc. |
Addressable protein arrays
|
US6440695B1
(en)
*
|
1998-04-17 |
2002-08-27 |
Whitehead Institute For Biomedical Research |
Method for producing diverse libraries of encoded polypeptides
|
US6562622B1
(en)
*
|
1998-05-08 |
2003-05-13 |
Diatech Pty, Ltd |
Continuous in vitro evolution
|
US20030170820A1
(en)
*
|
1998-05-08 |
2003-09-11 |
Gregory Coia |
Continuous in- vitro evolution
|
GB9810756D0
(en)
|
1998-05-19 |
1998-07-15 |
Angeletti P Ist Richerche Bio |
Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof
|
AU4854999A
(en)
*
|
1998-07-02 |
2000-01-24 |
Invitro Diagnostics, Inc. |
Methods, compositions and apparatus for making nucleic acid molecules having a selected affinity to a target molecule
|
US20040106110A1
(en)
*
|
1998-07-30 |
2004-06-03 |
Solexa, Ltd. |
Preparation of polynucleotide arrays
|
US20100130368A1
(en)
*
|
1998-07-30 |
2010-05-27 |
Shankar Balasubramanian |
Method and system for sequencing polynucleotides
|
US20030022207A1
(en)
*
|
1998-10-16 |
2003-01-30 |
Solexa, Ltd. |
Arrayed polynucleotides and their use in genome analysis
|
US6787308B2
(en)
|
1998-07-30 |
2004-09-07 |
Solexa Ltd. |
Arrayed biomolecules and their use in sequencing
|
US20040002101A1
(en)
*
|
1998-08-12 |
2004-01-01 |
Proteus S.A. |
Method and kit for discovering nucleic acids that encode desired functions
|
WO2000009737A1
(en)
|
1998-08-17 |
2000-02-24 |
Phylos, Inc. |
Methods for producing nucleic acids lacking 3'-untranslated regions and optimizing cellular rna-protein fusion formation
|
US6602685B1
(en)
|
1998-08-17 |
2003-08-05 |
Phylos, Inc. |
Identification of compound-protein interactions using libraries of protein-nucleic acid fusion molecules
|
US20060088846A1
(en)
|
1998-08-28 |
2006-04-27 |
Michele Pagano |
Methods to identify compounds useful for the treatment of proliferative and differentiative disorders
|
WO2000032823A1
(en)
|
1998-12-02 |
2000-06-08 |
Phylos, Inc. |
Dna-protein fusions and uses thereof
|
US6914128B1
(en)
|
1999-03-25 |
2005-07-05 |
Abbott Gmbh & Co. Kg |
Human antibodies that bind human IL-12 and methods for producing
|
US7883704B2
(en)
*
|
1999-03-25 |
2011-02-08 |
Abbott Gmbh & Co. Kg |
Methods for inhibiting the activity of the P40 subunit of human IL-12
|
CN101066997B
(zh)
|
1999-03-25 |
2013-03-27 |
艾博特股份有限两合公司 |
结合人il-12的人抗体及其生产方法
|
EP2385124B1
(en)
|
1999-05-14 |
2013-09-11 |
Arbor Vita Corporation |
Peptides or peptide analogues for modulating the binding of a PDZ protein and a PL protein
|
US6623926B1
(en)
|
1999-06-01 |
2003-09-23 |
Phylos, Inc. |
Methods for producing 5′-nucleic acid-protein conjugates
|
US20030091999A1
(en)
*
|
1999-10-01 |
2003-05-15 |
Zhongping Yu |
Compositions and methods for identifying polypeptides and nucleic acid molecules
|
US7022479B2
(en)
|
2000-01-24 |
2006-04-04 |
Compound Therapeutics, Inc. |
Sensitive, multiplexed diagnostic assays for protein analysis
|
EP1250463B1
(en)
|
2000-01-24 |
2006-04-05 |
Compound Therapeutics, Inc. |
Sensitive, multiplexed diagnostic assays for protein analysis
|
WO2001075097A2
(en)
*
|
2000-03-31 |
2001-10-11 |
Cambridge Antibody Technology Limited |
Improvements to ribosome display
|
CA2405557C
(en)
|
2000-04-12 |
2013-09-24 |
Human Genome Sciences, Inc. |
Albumin fusion proteins
|
US6902734B2
(en)
|
2000-08-07 |
2005-06-07 |
Centocor, Inc. |
Anti-IL-12 antibodies and compositions thereof
|
UA81743C2
(uk)
|
2000-08-07 |
2008-02-11 |
Центокор, Инк. |
МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ
|
US7288390B2
(en)
|
2000-08-07 |
2007-10-30 |
Centocor, Inc. |
Anti-dual integrin antibodies, compositions, methods and uses
|
EP1674477B1
(en)
|
2000-08-18 |
2009-12-09 |
Dyax Corp. |
Binding polypeptides for B lymphocyte stimulator protein (BLYS)
|
WO2002020565A2
(en)
|
2000-09-08 |
2002-03-14 |
Universität Zürich |
Collections of repeat proteins comprising repeat modules
|
JP4723713B2
(ja)
*
|
2000-09-25 |
2011-07-13 |
トヨタ自動車株式会社 |
mRNAの潜在的翻訳制御因子のスクリーニング方法
|
US20040091509A1
(en)
*
|
2000-12-14 |
2004-05-13 |
Avon Products, Inc. |
Skin care composition that mediates cell to cell communication
|
KR100401296B1
(ko)
*
|
2000-12-27 |
2003-10-11 |
드림바이오젠 주식회사 |
수식물질에 의해 수식된 단백질 변이체 및 이것의 제조방법
|
JP4061043B2
(ja)
|
2000-12-28 |
2008-03-12 |
株式会社ポストゲノム研究所 |
invitro転写/翻訳系によるペプチド等の製造方法
|
DK1423400T4
(da)
|
2001-03-19 |
2013-09-02 |
Harvard College |
Evolution af hidtil ukendt molekylfunktion
|
EP1249499A1
(de)
*
|
2001-04-10 |
2002-10-16 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Verfahren und Vorrichtung zur Bestimmung und Selektion von Molekül-Molekül-Wechselwirkungen
|
DK1385864T3
(da)
|
2001-04-13 |
2010-08-16 |
Human Genome Sciences Inc |
Anti-VEGF-2-antistoffer
|
CN1539014A
(zh)
|
2001-06-20 |
2004-10-20 |
ŦΤ¬ɭ��˾ |
模控分子和使用这种分子的方法
|
WO2002102820A1
(en)
|
2001-06-20 |
2002-12-27 |
Nuevolution A/S |
Nucleoside derivatives for library preparation
|
GB0115841D0
(en)
|
2001-06-28 |
2001-08-22 |
Medical Res Council |
Ligand
|
EP1440083B1
(en)
|
2001-10-25 |
2013-01-02 |
Medical Research Council |
Molecules
|
GB0126887D0
(en)
*
|
2001-11-08 |
2002-01-02 |
Univ London |
Method for producing and identifying soluble protein domains
|
GB0127564D0
(en)
|
2001-11-16 |
2002-01-09 |
Medical Res Council |
Emulsion compositions
|
US20030162209A1
(en)
*
|
2001-12-19 |
2003-08-28 |
George Martin |
PCR based high throughput polypeptide screening
|
US20040052928A1
(en)
*
|
2002-09-06 |
2004-03-18 |
Ehud Gazit |
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
|
US7781396B2
(en)
*
|
2002-01-31 |
2010-08-24 |
Tel Aviv University Future Technology Development L.P. |
Peptides directed for diagnosis and treatment of amyloid-associated disease
|
US20030166282A1
(en)
*
|
2002-02-01 |
2003-09-04 |
David Brown |
High potency siRNAS for reducing the expression of target genes
|
US20060009409A1
(en)
|
2002-02-01 |
2006-01-12 |
Woolf Tod M |
Double-stranded oligonucleotides
|
WO2003064625A2
(en)
|
2002-02-01 |
2003-08-07 |
Sequitur, Inc. |
Oligonucleotide compositions with enhanced efficiency
|
AU2003217716A1
(en)
*
|
2002-02-25 |
2003-09-09 |
Cabot Corporation |
Custom ligand design for biomolecular filtration and purification for bioseperation
|
IL163822A0
(en)
|
2002-03-15 |
2005-12-18 |
Nuevolution As |
An improved method for synthesising templated molecules
|
WO2003087313A2
(en)
|
2002-04-08 |
2003-10-23 |
Pioneer Hi-Bred International, Inc. |
Enhanced silk exsertion under stress
|
DE60328979D1
(de)
|
2002-05-10 |
2009-10-08 |
Jackson H M Found Military Med |
Androgen-reguliertes pmepa1 gen und verfahren zu seiner verwendung zur hemmung von krebszellwachstum
|
US20100075423A1
(en)
*
|
2002-06-12 |
2010-03-25 |
Life Technologies Corporation |
Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interference
|
WO2003106630A2
(en)
*
|
2002-06-12 |
2003-12-24 |
Ambion, Inc. |
Methods and compositions relating to polypeptides with rnase iii domains that mediate rna interference
|
US20040248094A1
(en)
*
|
2002-06-12 |
2004-12-09 |
Ford Lance P. |
Methods and compositions relating to labeled RNA molecules that reduce gene expression
|
US20060002935A1
(en)
|
2002-06-28 |
2006-01-05 |
Domantis Limited |
Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor
|
US9321832B2
(en)
|
2002-06-28 |
2016-04-26 |
Domantis Limited |
Ligand
|
US10730906B2
(en)
|
2002-08-01 |
2020-08-04 |
Nuevolutions A/S |
Multi-step synthesis of templated molecules
|
WO2004016767A2
(en)
|
2002-08-19 |
2004-02-26 |
The President And Fellows Of Harvard College |
Evolving new molecular function
|
CA2497496C
(en)
|
2002-09-06 |
2012-05-15 |
Isogenica Limited |
In vitro peptide expression library
|
EP1537415B1
(en)
|
2002-09-09 |
2008-12-17 |
Arbor Vita Corporation |
Methods of diagnosing cervical cancer
|
AU2003266932B2
(en)
|
2002-09-27 |
2009-04-09 |
Mpm-Holding Aps |
Spatially encoded polymer matrix
|
PT1558744E
(pt)
|
2002-10-30 |
2011-09-22 |
Nuevolution As |
Codificação enzimática
|
US20060275833A1
(en)
*
|
2002-11-04 |
2006-12-07 |
Icogenex Corporation |
Methods for the identification of agents that modulate the structure and processing of a membrane bound precursor protein
|
AU2003285151A1
(en)
*
|
2002-11-04 |
2004-06-07 |
Bioarctic Neuroscience Ab |
Methods for the identification of agents that modulate the structure and processing of beta-amyloid precursor protein
|
US7491699B2
(en)
|
2002-12-09 |
2009-02-17 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures and methods of generating and using the same
|
ATE450609T1
(de)
|
2002-12-19 |
2009-12-15 |
Nuevolution As |
Durch quasizufallsstrukturen und funktionen geführte synthesemethode
|
EP2058275A1
(en)
*
|
2003-01-07 |
2009-05-13 |
Ramot at Tel-Aviv University Ltd. |
Peptide nanostructures encapsulating a foreign material and method of manufacturing same
|
DE602004036672C5
(de)
|
2003-01-29 |
2012-11-29 |
454 Life Sciences Corporation |
Nukleinsäureamplifikation auf Basis von Kügelchenemulsion
|
US20070026397A1
(en)
|
2003-02-21 |
2007-02-01 |
Nuevolution A/S |
Method for producing second-generation library
|
ATE424455T1
(de)
|
2003-03-20 |
2009-03-15 |
Nuevolution As |
Ligationsvermittelnde codierung von kleinen molekülen
|
GB0307403D0
(en)
|
2003-03-31 |
2003-05-07 |
Medical Res Council |
Selection by compartmentalised screening
|
US20060078893A1
(en)
|
2004-10-12 |
2006-04-13 |
Medical Research Council |
Compartmentalised combinatorial chemistry by microfluidic control
|
GB0307428D0
(en)
|
2003-03-31 |
2003-05-07 |
Medical Res Council |
Compartmentalised combinatorial chemistry
|
US9708410B2
(en)
|
2003-05-30 |
2017-07-18 |
Janssen Biotech, Inc. |
Anti-tissue factor antibodies and compositions
|
US8048627B2
(en)
|
2003-07-05 |
2011-11-01 |
The Johns Hopkins University |
Method and compositions for detection and enumeration of genetic variations
|
US7585815B2
(en)
*
|
2003-07-24 |
2009-09-08 |
Lawrence Livermore National Security, Llc |
High throughput protein production screening
|
EP2325339A3
(en)
|
2003-09-09 |
2011-11-02 |
Integrigen, Inc. |
Methods and compositions for generation of germline human antibody genes
|
ATE447626T1
(de)
|
2003-09-18 |
2009-11-15 |
Nuevolution As |
Methode zur gewinnung struktureller informationen kodierter moleküle und zur selektion von verbindungen
|
WO2005027901A1
(en)
*
|
2003-09-25 |
2005-03-31 |
Tel Aviv University Future Technology Development L.P. |
Compositions and methods using same for treating amyloid-associated diseases
|
US7625707B2
(en)
*
|
2003-10-02 |
2009-12-01 |
Ramot At Tel Aviv University Ltd. |
Antibacterial agents and methods of identifying and utilizing same
|
CA2549386C
(en)
|
2003-12-17 |
2014-07-29 |
Praecis Pharmaceuticals, Inc. |
Methods for synthesis of encoded libraries
|
US7972994B2
(en)
|
2003-12-17 |
2011-07-05 |
Glaxosmithkline Llc |
Methods for synthesis of encoded libraries
|
WO2005061548A1
(en)
|
2003-12-23 |
2005-07-07 |
Nono Inc. |
Polypeptides for modulating binding of trp channel proteins and trp-associated proteins.
|
EP1730277B1
(en)
|
2004-03-22 |
2009-10-28 |
Nuevolution A/S |
Ligational encoding using building block oligonucleotides
|
US20050221339A1
(en)
|
2004-03-31 |
2005-10-06 |
Medical Research Council Harvard University |
Compartmentalised screening by microfluidic control
|
US8318488B1
(en)
|
2004-05-11 |
2012-11-27 |
Axiogenesis Ag |
Assay for drug discovery based on in vitro differentiated cells
|
WO2006006172A2
(en)
*
|
2004-07-15 |
2006-01-19 |
Ramot At Tel Aviv University Ltd. |
Use of anti-amyloid agents for treating and typing pathogen infections
|
US8568637B2
(en)
*
|
2004-08-02 |
2013-10-29 |
Ramot At Tel-Aviv University Ltd. |
Method of forming a fiber made of peptide nanostructures
|
EP1793816B1
(en)
|
2004-08-19 |
2012-01-04 |
Tel Aviv University Future Technology Development L.P. |
Compositions for treating amyloid associated diseases
|
TWI364458B
(en)
*
|
2004-08-27 |
2012-05-21 |
Wyeth Res Ireland Ltd |
Production of tnfr-lg
|
TWI374935B
(en)
|
2004-08-27 |
2012-10-21 |
Pfizer Ireland Pharmaceuticals |
Production of α-abeta
|
TWI384069B
(zh)
|
2004-08-27 |
2013-02-01 |
Pfizer Ireland Pharmaceuticals |
多胜肽之製法
|
US7786086B2
(en)
*
|
2004-09-08 |
2010-08-31 |
Ramot At Tel-Aviv University Ltd. |
Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same
|
RU2401842C2
(ru)
|
2004-10-08 |
2010-10-20 |
Домантис Лимитед |
Антагонисты и способы их применения
|
US7968287B2
(en)
|
2004-10-08 |
2011-06-28 |
Medical Research Council Harvard University |
In vitro evolution in microfluidic systems
|
KR100730875B1
(ko)
|
2004-12-07 |
2007-06-20 |
가부시키가이샤 시마즈세이사쿠쇼 |
번역반응 촉진 dna 단편 및 그것을 사용한 무세포계단백질 합성방법
|
US20060142228A1
(en)
*
|
2004-12-23 |
2006-06-29 |
Ambion, Inc. |
Methods and compositions concerning siRNA's as mediators of RNA interference
|
CA2601400A1
(en)
|
2005-03-19 |
2006-09-28 |
Medical Research Council |
Improvements in or relating to treatment and prevention of viral infections
|
JO3058B1
(ar)
|
2005-04-29 |
2017-03-15 |
Applied Molecular Evolution Inc |
الاجسام المضادة لمضادات -اي ال-6,تركيباتها طرقها واستعمالاتها
|
WO2006123445A1
(ja)
*
|
2005-05-18 |
2006-11-23 |
Kyoto University |
タンパク質の表示方法
|
CN101252951B
(zh)
|
2005-06-30 |
2011-12-21 |
森托科尔公司 |
抗il-23抗体、组合物、方法和用途
|
CA2617539A1
(en)
|
2005-07-01 |
2007-01-11 |
Washington University In St. Louis |
Phosphospecific chemokine receptor antibodies
|
WO2007011722A2
(en)
|
2005-07-15 |
2007-01-25 |
President And Fellows Of Harvard College |
Reaction discovery system
|
US20070111237A1
(en)
*
|
2005-09-14 |
2007-05-17 |
Maurizio Zanetti |
Process for identifying antigenized antibodies using ribosome cell free expression system
|
US10004828B2
(en)
*
|
2005-10-11 |
2018-06-26 |
Romat at Tel-Aviv University Ltd. |
Self-assembled Fmoc-ff hydrogels
|
EP2368868A1
(en)
|
2005-10-28 |
2011-09-28 |
Praecis Pharmaceuticals Inc. |
Methods for identifying compounds of interest using encoded libraries
|
US7879212B2
(en)
*
|
2005-11-03 |
2011-02-01 |
Ramot At Tel-Aviv University Ltd. |
Peptide nanostructure-coated electrodes
|
DK3305900T3
(da)
|
2005-12-01 |
2021-10-25 |
Nuevolution As |
Enzymatic encoding methods for efficient synthesis of large libraries
|
EP1971366B1
(en)
|
2005-12-29 |
2014-07-30 |
Janssen Biotech, Inc. |
Human anti-il-23 antibodies, compositions, methods and uses
|
JP2009536313A
(ja)
|
2006-01-11 |
2009-10-08 |
レインダンス テクノロジーズ, インコーポレイテッド |
ナノリアクターの形成および制御において使用するマイクロ流体デバイスおよび方法
|
JP2009529915A
(ja)
|
2006-03-20 |
2009-08-27 |
ゾーマ テクノロジー リミテッド |
ガストリン物質に対して特異的なヒト抗体および方法
|
US7749957B2
(en)
|
2006-04-06 |
2010-07-06 |
E.I. Du Pont De Nemours And Company |
Clay-binding peptides and methods of use
|
US20080014589A1
(en)
|
2006-05-11 |
2008-01-17 |
Link Darren R |
Microfluidic devices and methods of use thereof
|
US9562837B2
(en)
|
2006-05-11 |
2017-02-07 |
Raindance Technologies, Inc. |
Systems for handling microfludic droplets
|
WO2008005290A2
(en)
|
2006-06-29 |
2008-01-10 |
The Trustees Of Columbia University In The City Of New York |
Methods for testing anti-thrombotic agents
|
DK2043671T3
(da)
|
2006-07-11 |
2020-06-15 |
Nono Inc |
Peptid og sammensætning deraf til anvendelse ved behandling af slagtilfælde med feber
|
US9012390B2
(en)
|
2006-08-07 |
2015-04-21 |
Raindance Technologies, Inc. |
Fluorocarbon emulsion stabilizing surfactants
|
US9580515B2
(en)
|
2006-08-21 |
2017-02-28 |
Zensun (Shanghai) Science & Technology, Co., Ltd. |
Neukinase, a downstream protein of neuregulin
|
WO2008060448A2
(en)
|
2006-11-10 |
2008-05-22 |
Massachusetts Institute Of Technology |
Small molecule pak inhibitors
|
CA2673592C
(en)
|
2006-12-20 |
2014-03-25 |
Xoma Technology Ltd. |
Methods for the treatment of il-1.beta. related diseases
|
CN104524567A
(zh)
*
|
2007-01-16 |
2015-04-22 |
阿布维公司 |
用于治疗银屑病的方法
|
US8772046B2
(en)
|
2007-02-06 |
2014-07-08 |
Brandeis University |
Manipulation of fluids and reactions in microfluidic systems
|
KR20100014674A
(ko)
*
|
2007-03-29 |
2010-02-10 |
아보트 러보러터리즈 |
결정성 항-사람 il-12 항체
|
US8592221B2
(en)
|
2007-04-19 |
2013-11-26 |
Brandeis University |
Manipulation of fluids, fluid components and reactions in microfluidic systems
|
JP2010534664A
(ja)
|
2007-07-23 |
2010-11-11 |
セントコア・オーソ・バイオテツク・インコーポレーテツド |
Il−17拮抗薬を用いた線維症関連疾患治療の方法及び組成物
|
US7951559B2
(en)
*
|
2007-07-25 |
2011-05-31 |
E.I. Du Pont De Nemours And Company |
Recombinant peptide production using a cross-linkable solubility tag
|
US7678883B2
(en)
*
|
2007-07-25 |
2010-03-16 |
E.I. Du Pont De Nemours And Company |
Solubility tags for the expression and purification of bioactive peptides
|
US7829311B2
(en)
|
2007-07-25 |
2010-11-09 |
E.I. Du Pont De Nemours And Company |
Ketosteroid isomerase inclusion body tag engineered to be acid-resistant by replacing aspartates with glutamate
|
US7794963B2
(en)
|
2007-11-02 |
2010-09-14 |
E.I. Du Pont De Nemours And Company |
Use of tetracysteine tags in fluorescence-activated cell sorting analysis of prokaryotic cells producing peptides or proteins
|
AR069392A1
(es)
|
2007-11-20 |
2010-01-20 |
Pioneer Hi Bred Int |
Genes de senalizacion de etileno en maiz y su modulacion para aumentar la tolerancia al estres en plantas
|
DK2391650T3
(en)
|
2007-12-20 |
2015-01-12 |
Xoma Us Llc |
Methods of treating gout
|
RU2497545C2
(ru)
*
|
2008-03-18 |
2013-11-10 |
Эбботт Лэборетриз |
Способ лечения псориаза (варианты)
|
GB0806562D0
(en)
|
2008-04-10 |
2008-05-14 |
Fermentas Uab |
Production of nucleic acid
|
SG176464A1
(en)
|
2008-05-09 |
2011-12-29 |
Agency Science Tech & Res |
Diagnosis and treatment of kawasaki disease
|
US12038438B2
(en)
|
2008-07-18 |
2024-07-16 |
Bio-Rad Laboratories, Inc. |
Enzyme quantification
|
WO2010009365A1
(en)
|
2008-07-18 |
2010-01-21 |
Raindance Technologies, Inc. |
Droplet libraries
|
ES2752025T3
(es)
*
|
2008-07-25 |
2020-04-02 |
Wagner Richard W |
Métodos de cribado de proteínas
|
JP5623401B2
(ja)
|
2008-08-14 |
2014-11-12 |
テバ・ファーマシューティカルズ・オーストラリア・ピーティワイ・リミテッド |
抗il−12/il−23抗体
|
JP2012503983A
(ja)
*
|
2008-09-26 |
2012-02-16 |
ワイス・エルエルシー |
適合性ディスプレイベクター系
|
EP2364359A2
(en)
|
2008-09-26 |
2011-09-14 |
Wyeth LLC |
Compatible display vector systems
|
US8278419B2
(en)
|
2008-10-31 |
2012-10-02 |
Centocor Ortho Biotech Inc. |
Fibronectin type III domain based scaffold compositions, methods and uses
|
EP2356270B1
(en)
|
2008-11-07 |
2016-08-24 |
Fabrus Llc |
Combinatorial antibody libraries and uses thereof
|
BRPI0921320A2
(pt)
*
|
2008-11-28 |
2018-05-22 |
Abbott Laboratories |
composições de anticorpo estáveis e métodos para estabilizar os mesmos
|
US8287845B2
(en)
*
|
2008-12-18 |
2012-10-16 |
E I Du Pont De Nemours And Company |
Hair-binding peptides
|
US20100158837A1
(en)
|
2008-12-18 |
2010-06-24 |
E. I. Du Pont De Nemours And Company |
Iron oxide-binding peptides
|
US20100158822A1
(en)
*
|
2008-12-18 |
2010-06-24 |
E .I. Du Pont De Nemours And Company |
Peptides that bind to silica-coated particles
|
US20100158846A1
(en)
*
|
2008-12-18 |
2010-06-24 |
E. I. Du Pont De Nemours And Company |
Hair-binding peptides
|
WO2010074783A1
(en)
|
2008-12-23 |
2010-07-01 |
The Trustees Of Columbia University In The City Of New York |
Phosphodiesterase inhibitors and uses thereof
|
EP2379076B1
(en)
|
2008-12-23 |
2014-11-12 |
The Trustees of Columbia University in the City of New York |
Phosphodiesterase inhibitors and uses thereof
|
WO2010093627A2
(en)
|
2009-02-12 |
2010-08-19 |
Centocor Ortho Biotech Inc. |
Fibronectin type iii domain based scaffold compositions, methods and uses
|
WO2010101818A1
(en)
|
2009-03-02 |
2010-09-10 |
Pioneer Hi-Bred International, Inc. |
Nac transcriptional activators involved in abiotic stress tolerance
|
US8528589B2
(en)
|
2009-03-23 |
2013-09-10 |
Raindance Technologies, Inc. |
Manipulation of microfluidic droplets
|
CA2758049A1
(en)
*
|
2009-03-30 |
2010-10-14 |
E.I. Du Pont De Nemours And Company |
Peptide-based systems for delivery of cosmetic agents
|
WO2010114638A1
(en)
|
2009-03-30 |
2010-10-07 |
E. I. Du Pont De Nemours And Company |
Peptide-based tooth whitening reagents
|
WO2011017492A2
(en)
|
2009-08-05 |
2011-02-10 |
Pioneer Hi-Bred International, Inc. |
Novel eto1 genes and use of same for reduced ethylene and improved stress tolerance in plants
|
KR101161622B1
(ko)
*
|
2009-08-31 |
2012-07-04 |
헬릭스 주식회사 |
번역 효율 증진용 dna 단편 및 이를 포함하는 재조합 벡터
|
AU2010291927A1
(en)
*
|
2009-09-14 |
2012-04-12 |
AbbVie Deutschland GmbH & Co. KG |
Methods for treating psoriasis
|
CA2772945A1
(en)
|
2009-09-25 |
2011-03-31 |
Xoma Technology Ltd. |
Screening methods
|
US8926976B2
(en)
|
2009-09-25 |
2015-01-06 |
Xoma Technology Ltd. |
Modulators
|
WO2011042564A1
(en)
|
2009-10-09 |
2011-04-14 |
Universite De Strasbourg |
Labelled silica-based nanomaterial with enhanced properties and uses thereof
|
US8580714B2
(en)
*
|
2009-10-14 |
2013-11-12 |
Janssen Biotech, Inc. |
Methods of affinity maturing antibodies
|
US20110165648A1
(en)
|
2009-11-04 |
2011-07-07 |
Menno Van Lookeren Campagne |
Co-crystal structure of factor D and anti-factor D antibody
|
IL201999A
(en)
|
2009-11-08 |
2017-10-31 |
Medical Res & Development Fund For Health Services Bnai Zion Medical Center The State Of Israel |
A knockout mouse of the 1 – mo gene, a gene associated with morbidly extreme obesity
|
US10640457B2
(en)
|
2009-12-10 |
2020-05-05 |
The Trustees Of Columbia University In The City Of New York |
Histone acetyltransferase activators and uses thereof
|
WO2011072243A1
(en)
|
2009-12-10 |
2011-06-16 |
The Trustees Of Columbia University In The City Of New York |
Histone acetyltransferase activators and uses thereof
|
US10837883B2
(en)
|
2009-12-23 |
2020-11-17 |
Bio-Rad Laboratories, Inc. |
Microfluidic systems and methods for reducing the exchange of molecules between droplets
|
WO2011100403A1
(en)
|
2010-02-10 |
2011-08-18 |
Immunogen, Inc |
Cd20 antibodies and uses thereof
|
WO2011100604A2
(en)
|
2010-02-12 |
2011-08-18 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
US10351905B2
(en)
|
2010-02-12 |
2019-07-16 |
Bio-Rad Laboratories, Inc. |
Digital analyte analysis
|
US9399797B2
(en)
|
2010-02-12 |
2016-07-26 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
US9366632B2
(en)
|
2010-02-12 |
2016-06-14 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
EP2546342A4
(en)
|
2010-03-11 |
2013-12-04 |
Riken |
METHOD FOR SELECTION OF A POLYPEPTIDE SEQUENCE, METAL OXIDE OR SILICON WITH A BONDING SPEPTIDE AND USE THEREOF
|
LT2558577T
(lt)
|
2010-04-16 |
2019-03-12 |
Nuevolution A/S |
Bifunkciniai kompleksai ir tokių kompleksų gamybos ir naudojimo būdai
|
BR112012027863B1
(pt)
|
2010-04-30 |
2023-03-07 |
Janssen Biotech, Inc |
Polipeptídeos, arcabouços de proteína, bibliotecas e métodos de construção das mesmas, método para gerar uma ligação de arcabouço de proteína a um alvo específico com uma afinidade de ligação predefinida, moléculas de ácido nucleico isolada, vetores, células hospedeiras, composições, dispositivos médicos, e artigos de fabricação
|
WO2012022734A2
(en)
|
2010-08-16 |
2012-02-23 |
Medimmune Limited |
Anti-icam-1 antibodies and methods of use
|
CA2807607A1
(en)
|
2010-08-20 |
2012-02-23 |
Wyeth Llc |
Cell culture of growth factor-free adapted cells
|
US8987415B2
(en)
|
2010-09-07 |
2015-03-24 |
Technische Universitaet Muenchen |
Recombinant bacterial lipocalin blc and uses thereof
|
US9562897B2
(en)
|
2010-09-30 |
2017-02-07 |
Raindance Technologies, Inc. |
Sandwich assays in droplets
|
KR102027394B1
(ko)
|
2010-11-02 |
2019-10-01 |
더 트러스티스 오브 콜롬비아 유니버시티 인 더 시티 오브 뉴욕 |
탈모 질환의 치료 방법
|
US9198911B2
(en)
|
2010-11-02 |
2015-12-01 |
The Trustees Of Columbia University In The City Of New York |
Methods for treating hair loss disorders
|
EP3323813B1
(en)
|
2010-12-22 |
2020-08-26 |
The Trustees of Columbia University in the City of New York |
Histone acetyltransferase modulators and uses thereof
|
DE102010056289A1
(de)
|
2010-12-24 |
2012-06-28 |
Geneart Ag |
Verfahren zur Herstellung von Leseraster-korrekten Fragment-Bibliotheken
|
US9364803B2
(en)
|
2011-02-11 |
2016-06-14 |
Raindance Technologies, Inc. |
Methods for forming mixed droplets
|
EP3736281A1
(en)
|
2011-02-18 |
2020-11-11 |
Bio-Rad Laboratories, Inc. |
Compositions and methods for molecular labeling
|
JP5948673B2
(ja)
|
2011-03-10 |
2016-07-06 |
ジーンフロンティア株式会社 |
リポ多糖混入量を低減した蛋白質合成用組成物、該組成物を用いた蛋白質製造方法
|
DE12722942T1
(de)
|
2011-03-31 |
2021-09-30 |
Modernatx, Inc. |
Freisetzung und formulierung von manipulierten nukleinsäuren
|
US20120301904A1
(en)
|
2011-04-26 |
2012-11-29 |
Prosetta Antiviral, Inc |
Multiprotein assemblies
|
JP6057297B2
(ja)
|
2011-05-23 |
2017-01-11 |
国立研究開発法人理化学研究所 |
核酸構築物、核酸−蛋白質複合体、及びその利用
|
EP2714970B1
(en)
|
2011-06-02 |
2017-04-19 |
Raindance Technologies, Inc. |
Enzyme quantification
|
US8841071B2
(en)
|
2011-06-02 |
2014-09-23 |
Raindance Technologies, Inc. |
Sample multiplexing
|
KR102051014B1
(ko)
|
2011-06-03 |
2019-12-04 |
조마 테크놀로지 리미티드 |
Tgf-베타에 특이적인 항체
|
US8658430B2
(en)
|
2011-07-20 |
2014-02-25 |
Raindance Technologies, Inc. |
Manipulating droplet size
|
WO2013033657A2
(en)
|
2011-09-02 |
2013-03-07 |
The Trustees Of Columbia University In The City Of New York |
CaMKII, IP3R, CALCINEURIN, P38 AND MK2/3 INHIBITORS TO TREAT METABOLIC DISTURBANCES OF OBESITY
|
DK2758433T3
(en)
|
2011-09-19 |
2018-01-15 |
Axon Neuroscience Se |
PROTEIN-BASED THERAPY AND DIAGNOSIS OF TAU-MEDIATED PATHOLOGY OF ALZHEIMER'S DISEASE
|
EP4151785A1
(en)
|
2011-09-27 |
2023-03-22 |
Janssen Biotech, Inc. |
Fibronectin type iii repeat based protein scaffolds with alternative binding surfaces
|
SG11201401220SA
(en)
|
2011-10-21 |
2014-07-30 |
Pfizer |
Addition of iron to improve cell culture
|
AR088515A1
(es)
|
2011-10-25 |
2014-06-18 |
Pioneer Hi Bred Int |
Metodos para alterar la composicion de la pared celular vegetal para obtener produccion de biocombustible y digestibilidad de silaje mejoradas
|
JP6320300B2
(ja)
|
2011-12-19 |
2018-05-09 |
ゾーマ (ユーエス) リミテッド ライアビリティ カンパニー |
座瘡を治療するための方法
|
CN104334191A
(zh)
|
2012-03-29 |
2015-02-04 |
纽约市哥伦比亚大学托管会 |
治疗毛发脱落疾病的方法
|
EP2833923A4
(en)
|
2012-04-02 |
2016-02-24 |
Moderna Therapeutics Inc |
MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
EP2657334B1
(en)
|
2012-04-26 |
2016-07-06 |
GeneFrontier Corporation |
Efficient method for displaying protein multimer
|
EP2850095B1
(en)
|
2012-05-17 |
2019-10-09 |
RA Pharmaceuticals, Inc. |
Peptide and peptidomimetic inhibitors
|
GB201214029D0
(en)
*
|
2012-08-07 |
2012-09-19 |
Queen Mary & Westfield College |
method
|
US9695228B2
(en)
|
2012-11-21 |
2017-07-04 |
Janssen Biotech, Inc. |
EGFR and c-Met fibronectin type III domain binding molecules
|
HUE041499T2
(hu)
|
2012-11-21 |
2019-05-28 |
Janssen Biotech Inc |
Bispecifikus EGFR/C-MET-ellenanyagok
|
EP2971033B8
(en)
|
2013-03-15 |
2019-07-10 |
ModernaTX, Inc. |
Manufacturing methods for production of rna transcripts
|
BR112015023703A2
(pt)
|
2013-03-15 |
2017-07-18 |
Pioneer Hi Bred Int |
modulação de expressão de deaminase de acc
|
EP2983804A4
(en)
|
2013-03-15 |
2017-03-01 |
Moderna Therapeutics, Inc. |
Ion exchange purification of mrna
|
EP4279610A3
(en)
|
2013-03-15 |
2024-01-03 |
ModernaTX, Inc. |
Ribonucleic acid purification
|
US10077439B2
(en)
|
2013-03-15 |
2018-09-18 |
Modernatx, Inc. |
Removal of DNA fragments in mRNA production process
|
JP7019233B2
(ja)
|
2013-07-11 |
2022-02-15 |
モデルナティエックス インコーポレイテッド |
CRISPR関連タンパク質をコードする合成ポリヌクレオチドおよび合成sgRNAを含む組成物ならびに使用方法
|
EP3052511A4
(en)
|
2013-10-02 |
2017-05-31 |
Moderna Therapeutics, Inc. |
Polynucleotide molecules and uses thereof
|
US11901041B2
(en)
|
2013-10-04 |
2024-02-13 |
Bio-Rad Laboratories, Inc. |
Digital analysis of nucleic acid modification
|
US10196446B2
(en)
|
2013-10-14 |
2019-02-05 |
Janssen Biotech, Inc. |
Cysteine engineered fibronectin type III domain binding molecules
|
US9309314B2
(en)
|
2013-12-03 |
2016-04-12 |
Agency For Science, Technology And Research (A*Star) |
Polypeptides, nucleic acids and uses thereof
|
US9944977B2
(en)
|
2013-12-12 |
2018-04-17 |
Raindance Technologies, Inc. |
Distinguishing rare variations in a nucleic acid sequence from a sample
|
DK3087098T3
(da)
|
2013-12-24 |
2020-06-08 |
Janssen Pharmaceutica Nv |
Anti-Vista-antistoffer og -fragmenter
|
US11193176B2
(en)
|
2013-12-31 |
2021-12-07 |
Bio-Rad Laboratories, Inc. |
Method for detecting and quantifying latent retroviral RNA species
|
EP3119876A1
(en)
|
2014-03-19 |
2017-01-25 |
Pfizer Inc. |
Method of cell culture
|
ES2750556T3
(es)
|
2014-06-12 |
2020-03-26 |
Ra Pharmaceuticals Inc |
Modulación de actividad del complemento
|
WO2015196128A2
(en)
|
2014-06-19 |
2015-12-23 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
JP6655074B2
(ja)
|
2014-06-20 |
2020-02-26 |
ジェネンテック, インコーポレイテッド |
シャガシンに基づく足場組成物、方法及び使用
|
US10407683B2
(en)
|
2014-07-16 |
2019-09-10 |
Modernatx, Inc. |
Circular polynucleotides
|
US9937222B2
(en)
|
2015-01-28 |
2018-04-10 |
Ra Pharmaceuticals, Inc. |
Modulators of complement activity
|
US10711067B2
(en)
|
2015-03-03 |
2020-07-14 |
Xoma (Us) Llc |
Treatment of post-prandial hyperinsulinemia and hypoglycemia after bariatric surgery
|
WO2016161410A2
(en)
|
2015-04-03 |
2016-10-06 |
Xoma Technology Ltd. |
Treatment of cancer using inhibitors of tgf-beta and pd-1
|
AU2016252773B2
(en)
|
2015-04-24 |
2022-06-02 |
Genentech, Inc. |
Multispecific antigen-binding proteins
|
BR112017023798A2
(pt)
|
2015-05-06 |
2018-10-16 |
Janssen Biotech Inc |
domínios fibronectina tipo iii de ligação a antígeno prostático específico de membrana
|
CA2990360C
(en)
|
2015-06-24 |
2024-02-13 |
Janssen Pharmaceutica Nv |
Anti-vista antibodies and fragments
|
US10253101B2
(en)
|
2015-08-06 |
2019-04-09 |
Xoma (Us) Llc |
Antibody fragments against the insulin receptor and uses thereof to treat hypoglycemia
|
US10647981B1
(en)
|
2015-09-08 |
2020-05-12 |
Bio-Rad Laboratories, Inc. |
Nucleic acid library generation methods and compositions
|
US11434486B2
(en)
|
2015-09-17 |
2022-09-06 |
Modernatx, Inc. |
Polynucleotides containing a morpholino linker
|
AU2016324463B2
(en)
|
2015-09-17 |
2022-10-27 |
Modernatx, Inc. |
Polynucleotides containing a stabilizing tail region
|
WO2017051347A2
(en)
|
2015-09-23 |
2017-03-30 |
Pfizer Inc. |
Cells and method of cell culture
|
PT3685847T
(pt)
|
2015-12-16 |
2023-03-14 |
Ra Pharmaceuticals Inc |
Moduladores de atividade de complemento
|
WO2017137830A1
(en)
|
2016-02-12 |
2017-08-17 |
Janssen Pharmaceutica Nv |
Anti-vista (b7h5) antibodies
|
EA201892190A1
(ru)
|
2016-03-29 |
2019-04-30 |
Янссен Байотек, Инк. |
Лечение псориаза антителом к ил-12 и/или ил-23 с возрастанием интервала между введениями дозы
|
JP7253923B2
(ja)
|
2016-04-05 |
2023-04-07 |
ファイザー・インク |
細胞培養プロセス
|
WO2017175058A1
(en)
|
2016-04-07 |
2017-10-12 |
Janssen Pharmaceutica Nv |
Anti-vista antibodies and fragments, uses thereof, and methods of identifying same
|
SG11201810687SA
(en)
|
2016-06-03 |
2018-12-28 |
Janssen Biotech Inc |
Serum albumin-binding fibronectin type iii domains
|
EA201990067A1
(ru)
|
2016-06-21 |
2019-07-31 |
Янссен Байотек, Инк. |
Цистеин-модифицированные связывающие молекулы на основе домена фибронектина iii типа
|
EP3475446A1
(en)
|
2016-06-27 |
2019-05-01 |
Juno Therapeutics, Inc. |
Method of identifying peptide epitopes, molecules that bind such epitopes and related uses
|
MA45491A
(fr)
|
2016-06-27 |
2019-05-01 |
Juno Therapeutics Inc |
Épitopes à restriction cmh-e, molécules de liaison et procédés et utilisations associés
|
EP3484927A1
(en)
|
2016-07-15 |
2019-05-22 |
Poseida Therapeutics, Inc. |
Chimeric antigen receptors (cars) specific for muc1 and methods for their use
|
KR20190052669A
(ko)
|
2016-07-15 |
2019-05-16 |
포세이다 테라퓨틱스, 인크. |
키메라 항원 수용체 및 사용 방법
|
WO2018026748A1
(en)
|
2016-08-01 |
2018-02-08 |
Xoma (Us) Llc |
Parathyroid hormone receptor 1 (pth1r) antibodies and uses thereof
|
KR20190046854A
(ko)
|
2016-09-14 |
2019-05-07 |
얀센 바이오테크 인코포레이티드 |
Bcma-특이적 피브로넥틴 iii 형 도메인을 포함하는 키메라 항원 수용체 및 그의 용도
|
CN110087681A
(zh)
|
2016-09-28 |
2019-08-02 |
佐马美国有限公司 |
结合白细胞介素-2的抗体和其用途
|
JP2020500152A
(ja)
|
2016-09-30 |
2020-01-09 |
ヤンセン バイオテツク,インコーポレーテツド |
抗il23特異的抗体で乾癬を治療する安全かつ有効な方法
|
EP3541422A4
(en)
|
2016-11-16 |
2020-05-06 |
Janssen Biotech, Inc. |
METHOD FOR TREATING PSORIASIS WITH A SPECIFIC ANTI-IL-23 ANTIBODY
|
EP3551210A1
(en)
|
2016-12-07 |
2019-10-16 |
RA Pharmaceuticals, Inc. |
Modulators of complement activity
|
EP3554561B1
(en)
|
2016-12-14 |
2023-06-28 |
Janssen Biotech, Inc. |
Cd137 binding fibronectin type iii domains
|
EP3932432A1
(en)
|
2016-12-14 |
2022-01-05 |
Janssen Biotech, Inc. |
Cd8a-binding fibronectin type iii domains
|
US10597438B2
(en)
|
2016-12-14 |
2020-03-24 |
Janssen Biotech, Inc. |
PD-L1 binding fibronectin type III domains
|
EP3354736B1
(en)
*
|
2017-01-25 |
2020-07-01 |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
Promoter construct for cell-free protein synthesis
|
KR20190113858A
(ko)
|
2017-01-30 |
2019-10-08 |
얀센 바이오테크 인코포레이티드 |
활성 건선성 관절염의 치료를 위한 항-tnf 항체, 조성물, 및 방법
|
MX2019009377A
(es)
|
2017-02-07 |
2019-12-11 |
Janssen Biotech Inc |
Anticuerpos anti-tnf, composiciones y metodos para el tratamiento de la espondilitis anquilosante activa.
|
CA3056227A1
(en)
|
2017-03-13 |
2018-09-20 |
Poseida Therapeutics, Inc. |
Compositions and methods for selective elimination and replacement of hematopoietic stem cells
|
US20200056190A1
(en)
|
2017-03-16 |
2020-02-20 |
Pfizer Inc. |
Tyrosine prototrophy
|
CN111727256A
(zh)
|
2017-09-08 |
2020-09-29 |
波赛达治疗公司 |
用于嵌合配体受体(clr)-介导的条件性基因表达的组合物和方法
|
JP2020533983A
(ja)
|
2017-09-15 |
2020-11-26 |
ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company |
目的のポリペプチドのラージスケールの製造間のオンラインバイオマス静電容量モニタリング
|
TW201922780A
(zh)
|
2017-09-25 |
2019-06-16 |
美商健生生物科技公司 |
以抗il12/il23抗體治療狼瘡之安全且有效之方法
|
WO2019150309A1
(en)
|
2018-02-02 |
2019-08-08 |
Hammack Scott |
Modulators of gpr68 and uses thereof for treating and preventing diseases
|
IL310216A
(en)
|
2018-03-05 |
2024-03-01 |
Janssen Biotech Inc |
Methods for treating Crohn's disease with a specific anti-IL23 antibody
|
US20210010055A1
(en)
|
2018-03-16 |
2021-01-14 |
Bristol-Myers Squibb Company |
Metabolic enzyme activity and disulfide bond reduction during protein production
|
US20190345245A1
(en)
|
2018-05-11 |
2019-11-14 |
Janssen Biotech, Inc. |
Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody
|
WO2020016838A2
(en)
|
2018-07-18 |
2020-01-23 |
Janssen Biotech, Inc. |
Sustained response predictors after treatment with anti-il23 specific antibody
|
LT3883606T
(lt)
|
2018-09-24 |
2023-09-11 |
Janssen Biotech, Inc. |
Saugus ir veiksmingas opinio kolito gydymo būdas anti-il12/il23 antikūnu
|
WO2020104943A2
(en)
|
2018-11-20 |
2020-05-28 |
Janssen Biotech, Inc. |
Safe and effective method of treating psoriasis with anti-il-23 specific antibody
|
US20220073942A1
(en)
|
2018-12-06 |
2022-03-10 |
Pfizer Inc. |
Cells with reduced inhibitor production and methods of use thereof
|
EP3897722A4
(en)
|
2018-12-18 |
2022-09-14 |
Janssen Biotech, Inc. |
SAFE AND EFFECTIVE METHOD OF TREATING LUPUS WITH AN ANTI-IL12/IL23 ANTIBODY
|
JP2022513507A
(ja)
|
2018-12-20 |
2022-02-08 |
ポセイダ セラピューティクス,インコーポレイティド |
ナノトランスポゾン組成物および使用方法
|
BR112021013903A2
(pt)
|
2019-01-15 |
2021-09-21 |
Janssen Biotech, Inc. |
Composições e métodos de anticorpos anti-tnf para o tratamento da artrite idiopática juvenil
|
CA3127748A1
(en)
|
2019-01-23 |
2020-07-30 |
Janssen Biotech, Inc. |
Anti-tnf antibody compositions for use in methods for the treatment of psoriatic arthritis
|
CN113365661A
(zh)
|
2019-01-31 |
2021-09-07 |
新加坡科技研究局 |
用于治疗或预防癌症的cnx/erp57抑制剂
|
WO2020183270A1
(en)
|
2019-03-14 |
2020-09-17 |
Janssen Biotech, Inc. |
Methods for producing anti-tnf antibody compositions
|
KR20210142002A
(ko)
|
2019-03-14 |
2021-11-23 |
얀센 바이오테크 인코포레이티드 |
항-tnf 항체 조성물을 생성하기 위한 제조 방법
|
KR20210141990A
(ko)
|
2019-03-14 |
2021-11-23 |
얀센 바이오테크 인코포레이티드 |
항-il12/il23 항체 조성물을 생성하기 위한 제조 방법
|
MA55284A
(fr)
|
2019-03-14 |
2022-01-19 |
Janssen Biotech Inc |
Procédés de production de compositions d'anticorps anti-tnf
|
WO2020188466A1
(en)
|
2019-03-18 |
2020-09-24 |
Janssen Biotech, Inc. |
Method of treating psoriasis in pediatric subjects with anti-il12/il23 antibody
|
CA3134016A1
(en)
|
2019-05-09 |
2020-11-12 |
Genentech, Inc. |
Methods of making antibodies
|
AU2020279987A1
(en)
|
2019-05-23 |
2021-11-18 |
Janssen Biotech, Inc. |
Method of treating inflammatory bowel disease with a combination therapy of antibodies to IL-23 and TNF alpha
|
CA3142580A1
(en)
|
2019-06-03 |
2020-12-10 |
Janssen Biotech, Inc. |
Anti-tnf antibodies, compositions, and methods for the treatment of active ankylosing spondylitis
|
AU2020289070A1
(en)
|
2019-06-03 |
2022-02-03 |
Janssen Biotech, Inc. |
Anti-TNF antibody compositions, and methods for the treatment of Psoriatic Arthritis
|
WO2021028752A1
(en)
|
2019-08-15 |
2021-02-18 |
Janssen Biotech, Inc. |
Anti-tfn antibodies for treating type i diabetes
|
CN114761424A
(zh)
|
2019-09-05 |
2022-07-15 |
波赛达治疗公司 |
同种异体细胞组合物和使用方法
|
US11781138B2
(en)
|
2019-10-14 |
2023-10-10 |
Aro Biotherapeutics Company |
FN3 domain-siRNA conjugates and uses thereof
|
WO2021076546A1
(en)
|
2019-10-14 |
2021-04-22 |
Aro Biotherapeutics Company |
Cd71 binding fibronectin type iii domains
|
CN115135672A
(zh)
|
2019-12-20 |
2022-09-30 |
波赛达治疗公司 |
抗muc1组合物和使用方法
|
US20230121433A1
(en)
|
2020-03-11 |
2023-04-20 |
Poseida Therapeutics, Inc. |
Chimeric stimulatory receptors and methods of use in t cell activation and differentiation
|
US20230190811A1
(en)
|
2020-04-14 |
2023-06-22 |
Poseida Therapeutics, Inc. |
Compositions and methods for use in the treatment of cancer
|
US20240000969A1
(en)
|
2020-10-21 |
2024-01-04 |
Poseida Therapeutics San Diego |
Compositions and methods for delivery of nucleic acids
|
EP4305061A1
(en)
|
2021-03-12 |
2024-01-17 |
Janssen Biotech, Inc. |
Safe and effective method of treating psoriatic arthritis with anti-il23 specific antibody
|
BR112023018400A2
(pt)
|
2021-03-12 |
2023-12-12 |
Janssen Biotech Inc |
Método para tratamento de pacientes de artrite psoriática com resposta inadequada à terapia de tnf com anticorpo específico anti-il23
|
MX2023012128A
(es)
|
2021-04-14 |
2024-01-11 |
Aro Biotherapeutics Company |
Dominios tipo iii de la fibronectina que se unen a cd71.
|
CN117916260A
(zh)
|
2021-07-09 |
2024-04-19 |
詹森生物科技公司 |
用于制备抗il12/il23抗体组合物的制造方法
|
WO2023281462A1
(en)
|
2021-07-09 |
2023-01-12 |
Janssen Biotech, Inc. |
Manufacturing methods for producing anti-tnf antibody compositions
|
JP2024526315A
(ja)
|
2021-07-09 |
2024-07-17 |
ヤンセン バイオテツク,インコーポレーテツド |
抗tnf抗体組成物を製造するための製造方法
|
KR20240095537A
(ko)
|
2021-10-04 |
2024-06-25 |
포세이다 테라퓨틱스, 인크. |
트랜스포존 조성물 및 이의 이용 방법
|
IL312401A
(en)
|
2021-10-29 |
2024-06-01 |
Janssen Biotech Inc |
Methods for treating Crohn's disease with a specific anti-IL23 antibody
|
WO2023079058A1
(en)
|
2021-11-05 |
2023-05-11 |
Yokogawa Insilico Biotechnology Gmbh |
Cell culture with reduced production of lactate
|
US20230151087A1
(en)
|
2021-11-15 |
2023-05-18 |
Janssen Biotech, Inc. |
Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody
|
IL313021A
(en)
|
2021-11-23 |
2024-07-01 |
Janssen Biotech Inc |
A method for treating ulcerative colitis with a specific anti-IL23 antibody
|
AU2023210287A1
(en)
|
2022-01-21 |
2024-09-05 |
Poseida Therapeutics, Inc. |
Compositions and methods for delivery of nucleic acids
|
KR20240139082A
(ko)
|
2022-02-02 |
2024-09-20 |
화이자 인코포레이티드 |
시스테인 프로토트로피
|
WO2023187707A1
(en)
|
2022-03-30 |
2023-10-05 |
Janssen Biotech, Inc. |
Method of treating mild to moderate psoriasis with il-23 specific antibody
|
WO2023223265A1
(en)
|
2022-05-18 |
2023-11-23 |
Janssen Biotech, Inc. |
Method for evaluating and treating psoriatic arthritis with il23 antibody
|
US20240199734A1
(en)
|
2022-11-22 |
2024-06-20 |
Janssen Biotech, Inc. |
Method of Treating Ulcerative Colitis with Anti-IL23 Specific Antibody
|